AI-generated summary
In this randomized, double-blind, placebo-controlled trial, the authors studied 20 healthy volunteers receiving 839/595 nm photobiomodulation or placebo on skin later exposed to photodynamic therapy. They report that skin reactions such as erythema, edema and pigment changes were unaffected by photobiomodulation under the study conditions.
- Participants
- 20
- Who or what was studied
- Healthy volunteers (n = 20)
- Wavelengths
- 839, 595 nm
- Limits stated in the abstract
- The abstract describes a small healthy-volunteer sample and results valid only under the stated study conditions.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 839 nm, 595 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photodynamic therapy, Photobiomodulation therapy, Placebo-controlled, Near-infrared, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.